Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

22
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
22
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

261
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
261
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

44
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
44
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.

Cephalalgia : an international journal of headache·2026
Same author

Redefining status migrainosus: A narrative review.

Headache·2026
Same author

Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine.

Cephalalgia : an international journal of headache·2025
Same author

Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study.

Neurology and therapy·2025
Same author

Milk and plasma pharmacokinetics of single-dose ubrogepant in healthy lactating women.

Headache·2025
Same author

Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial.

Nature medicine·2025
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

Pain reduction and tolerability of mirogabalin in trigeminal neuralgia: A prospective observational study.

Headache·2026
Same journal

Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

Sexual dysfunction is underrecognized in patients with migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

College students' migraine perceptions and lived experiences: A qualitative study.

Headache·2026
Same journal

A patient-centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System.

Headache·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

6.8K

Giant cell arteritis.

Jonathan H Smith1, Jerry W Swanson

  • 1Kentucky Neuroscience Institute, University of Kentucky, Lexington, KY, USA.

Headache
|July 22, 2014
PubMed
Summary
This summary is machine-generated.

Giant cell arteritis (GCA) is a vasculitis causing headaches in adults over 50. Early diagnosis and corticosteroid treatment are crucial to prevent vision loss, even with atypical symptoms.

Keywords:
cranial arteritiselderlygiant cell arteritisolder adultsecondary headachetemporal arteritis

More Related Videos

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.2K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

16.5K

Related Experiment Videos

Last Updated: Apr 26, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

6.8K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.2K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

16.5K

Area of Science:

  • Rheumatology
  • Neurology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a medium-to-large vessel vasculitis.
  • It is a significant cause of secondary headaches in individuals over 50.
  • Atypical presentations can delay diagnosis.

Purpose of the Study:

  • To review the diagnosis and management of GCA.
  • To highlight the importance of timely treatment.
  • To discuss diagnostic modalities and complications.

Main Methods:

  • Review of current literature on GCA diagnosis and management.
  • Discussion of classic and atypical GCA presentations.
  • Analysis of diagnostic tools including temporal artery biopsy (TAB) and imaging.

Main Results:

  • GCA can present atypically, delaying diagnosis.
  • Corticosteroids are vital for preventing vision loss.
  • TAB is the gold standard, but imaging aids diagnosis.
  • Relapse monitoring and management of steroid complications are key.

Conclusions:

  • Prompt diagnosis and corticosteroid initiation are critical for GCA patients.
  • Advanced imaging can supplement TAB in diagnosis.
  • Managing corticosteroid side effects and considering steroid-sparing agents are important for long-term care.